Short answer
ORTHOPEDIATRICS CORP (KIDS) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $73M (up 18.6% year over year) with net income of −$6M.
Q3 2026 key financials · XBRL
- Revenue
- $73M
- +18.6% YoY · +3.1% QoQ
- Net income
- −$6M
- +49.6% YoY · +17.2% QoQ
- Operating margin
- -5.8%
- Gross margin
- 74.3%
- EPS (diluted)
- −$0.24
- +52.0% YoY · +20.0% QoQ
Source: XBRL data from the ORTHOPEDIATRICS CORP (KIDS) Q3 2026 10-Q on SEC EDGAR. USD.
ORTHOPEDIATRICS CORP Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $72.7M, up 19% YoY from $61.2M
- Gross margin 74% vs 74% YoY; net loss $5.9M vs $11.8M
- Best segment Trauma and deformity: $52.6M, up 19%; worst Sports medicine/other: unchanged
- Operating cash flow $2.1M vs $(15.2)M; liquidity $44.9M at September 30
- Near-term losses possible amid portfolio expansion and consigned-set investments; $20.0M delayed-draw facility undrawn
Risk Factors
- No material changes to 10-K risk factors filed March 4, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ORTHOPEDIATRICS CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.